Skip to content
Screener

Medpace Holdings, Inc. MEDP Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)

Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$267M+8.6%
NeoGenomics logo
NeoGenomicsNEO
$29.53M-1.5%
RFL
Rafael Holdings, Inc.RFL
$130K0.0%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$26.74M+13.4%

Other financials

Income statement

See full
Revenue$707.3M+17.2%
Operating income$146.8M+16.2%
Net income$121.4M+34.5%
EPS (diluted)$4.25+37.1%

Balance sheet

See full
Cash & equivalents$502.7M+985%
Total debt$144.1M-3.8%
Total equity$433.9M+152%
Total assets$2.1B+30.9%

Cash flow

See full
Operating cash flow$162.0M+9.1%
CapEx$23.9M+291%
Free cash flow$138.1M-3.0%

Valuation

See full
Market cap$16.81B+33.1%
Enterprise value$16.46B+29.2%
P/E34.2×+4.0×
P/S+0.4×

Profitability

See full
Operating margin21%-0.4pp
Net margin17.7%-1.1pp
FCF margin25.4%-0.6pp

Returns & leverage

See full
Return on equity162.2%+72.8pp
Debt / equity0.3×-0.5×
Current ratio0.7×+0.3×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths.

The source filing: Medpace Holdings, Inc.’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001668397-26-000025
Line itemAmortizationAmortization
Remainder of 2026$$310
2027577
2028577
$$1,464

Item 1. Financial Statements (unaudited)

FAQ

What is Medpace Holdings, Inc.'s finite-lived intangible assets - expected amortization expense (year one)?
Medpace Holdings, Inc. (MEDP) reported finite-lived intangible assets - expected amortization expense (year one) of $577K in Q2 2026.
How has Medpace Holdings, Inc.'s finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?
Medpace Holdings, Inc.'s finite-lived intangible assets - expected amortization expense (year one) decreased by 6.9% year-over-year, from $620K to $577K.
What does finite-lived intangible assets - expected amortization expense (year one) mean?
This metric forecasts the amortization expense expected to be recognized in the upcoming fiscal year for intangible assets with finite useful lives. It provides visibility into the non-cash earnings impact of previously acquired intangible assets. Analysts use this to refine future earnings projections and cash flow models.

Ask your AI about Medpace Holdings, Inc.'s finite-lived intangible assets - expected amortization expense (year one).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude